917 results on '"Cazenave, J.-P."'
Search Results
2. Gene induction during differentiation of human monocytes into dendritic cells: an integrated study at the RNA and protein levels
3. Effect of Landscape Changes on Water Quality and Health Status of Heptapterus mustelinus (Siluriformes, Heptapteridae)
4. Éthique et transfusion sanguine – Échos d’un séminaire –
5. Transgenic Animals in Primary Hemostasis and Thrombosis
6. Soluble CD16/FcγRIII Induces Maturation of Dendritic Cells and Production of Several Cytokines Including IL-12
7. Platelet ADP/Purinergic Receptors
8. Mechanisms underlying FeCl3‐induced arterial thrombosis
9. Inactivation des pathogènes des concentrés plaquettaires : expérience française
10. Inactivation photochimique des pathogènes des plaquettes et du plasma : cinq ans d’utilisation clinique de routine et d’hémovigilance. Vers un changement de paradigme de la sécurité en transfusion
11. Plaquettes de culture : pourquoi ? Comment ? Quand ?
12. Platelet adhesion to surfaces
13. A Centrifugation Technique for the Preparation of Suspensions of Non Activated Washed Human Platelets
14. Platelet Deposition on Biomaterials measured with a Capillary Perfusion Model
15. Quantitative Platelet Aggregation In Vitro
16. Human Adult Endothelial Cell Culture Conditions for Optimal Colonization of Biomaterials Used in Vascular Surgery
17. Perfusion Technique for in Vitro Evaluation of Platelet Interaction with Biomaterials in Catheter Form
18. Proplatelet formation deficit and megakaryocyte death contribute to thrombocytopenia in Myh9 knockout mice
19. Immature myeloid dendritic cells capture and remove activated platelets from preformed aggregates
20. The platelet glycoprotein GPIbβ intracellular domain participates in von Willebrand factor induced-filopodia formation independently of the Ser 166 phosphorylation site
21. Arterial thrombosis: relevance of a model with two levels of severity assessed by histologic, ultrastructural and functional characterization
22. Survenue d’une thrombopénie sévère et durable, au décours d’une greffe de moelle allogénique, imputable à l’existence chez l’hôte d’une allo-immunisation anti-HPA-1
23. Pharmacological Inhibition of the ADP-GP IIb/IIIa-Fibrinogen Pathway of Platelet Aggregation
24. Methods to study blood-surface interactions
25. Évolution des techniques de préparation des produits sanguins labiles (PSL) : inactivation des pathogènes dans les PSL
26. Competitive Adsorption of Human Immunoglobulin G and Albumin: Consequences for Structure and Reactivity of the Adsorbed Layer
27. Prevention of transfusion-transmitted cytomegalovirus (CMV) infection: Standards of care
28. Prevention of transfusion-transmitted cytomegalovirus (CMV) infection: Standards of care
29. Bacterial contamination in platelet concentrates
30. Les bactéries : je dépiste ou j’inactive ?
31. Thrombotic tendencies and bleeding in a thrombocytosis mouse model: OC 89.6
32. Inhibition of Plasma Cholinesterase and Acute Toxicity of Monocrotophos in a Neotropical Fish Prochilodus lineatus (Pisces, Curimatidae)
33. Inhibition of adhesive and signaling functions of the platelet GPIb‐V‐IX complex by a cell penetrating GPIbα peptide
34. PRESERVED FUNCTIONAL AND BIOCHEMICAL CHARACTERISTICS OF PLATELET COMPONENTS PREPARED WITH AMOTOSALEN AND UVA FOR PATHOGEN INACTIVATION: 4C-S30–01
35. A NEW DEHYDRATION METHOD TO STORE BLOOD PLATELETS: ZEODRATION: 3C-S10–03
36. Reticulocytes and solvents an epidemiological study
37. COMPARATIVE EFFECTIVENESS OF PLASMA PREPARED WITH PATHOGEN INACTIVATION (INTERCEPT≤) AND QUARANTINE CONVENTIONAL PLASMA FOR SUPPORT OF LIVER TRANSPLANTATION: 4D-S17–04
38. Monitoring photochemical pathogen inactivation treatment using amotosalen and ultraviolet-A light: evaluation of an indicator label
39. A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology
40. Pathogen inactivation of platelet concentrates
41. Inventory Management
42. ACTIVE HEMOVIGILANCE OF PEDIATRIC PATIENTS SUPPORTED WITH PLASMA COMPONENTS PREPARED WITH PHOTOCHEMICAL TREATMENT (INTERCEPTTM): P-245
43. CYP2C19*2 polymorphism is not the sole determinant of the response to clopidogrel: implications for its monitoring
44. Evidence for Humoral Rejection of a Pancreatic Islet Graft and Rescue with Rituximab and IV Immunoglobulin Therapy
45. Further pharmacological and histological characterization of a model of laser-induced localized thrombosis in mesenteric arterioles with standardized moderate and severe injuries: OC-TH-034
46. Localized arterial thrombosis on ruptured atherosclerotic plaques of ApoE−/− mice after vascular injury with ultrasound: OC-TH-033
47. The relative contribution of the CYP2C19*2 polymorphism in the low responsiveness to clopidogrel in the VASP02 study: OC-MO-008
48. AN ACTIVE HEMOVIGILANCE PROGRAM UTILIZING AN EDC SYSTEM TO ASSESS SAFETY OF 6359 PLASMA COMPONENT TRANSFUSIONS PREPARED WITH THE INTERCEPT BLOOD SYSTEM: P-354
49. Actualités en transfusion sur la conservation des plaquettes
50. Programme en transfusion des étudiants en médecine
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.